HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.
International Cancer Research Conference
March 24-26, 2025 | Singapore
Organ Specific Cancer
Organ Specific Cancer
After cardiovascular disorders, cancer is the world 's second leading cause of mortality. The location of the cancer in the bodily organ determines the type of cancer. Different forms of cancer have different metabolic behaviors that are sometimes conflicting. Nonetheless, the oncogenic phenotype is supported by each cancer's unique metabolism. The immuno-biological microenvironments at distinct metastatic organ sites are major factors for variances in efficacy, and immunotherapy benefits a small proportion of patients across multiple cancer types. Recent advancements in cancer diagnosis and treatment, cancer survival has increased, and so there is a greater emphasis on quality rather than quantity of survival.
- Breast
- Digestive/Gastrointestinal
- Endocrine and Neuroendocrine
- Eye
- Genitourinary
- Germ Cell
- Gynecologic
- Head and Neck
- Blood
- Musculoskeletal
- Neurologic
- Respiratory/Thoracic
- Skin
- AIDS-Related
Committee Members
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
Seattle Children’s Hospital, United States
Michael Thompson
University of Toronto, Canada Cancer Research 2025 Speakers
Mariola Wioletta Borowska
Maria Sklodowska-Curie National Research Institute of Oncology, Poland
Andrea González Báez
Autonomous University of Nuevo Leon, Mexico
Qian Zhang
The Affiliated Changzhou Second People’s Hospital of Nanjing Medical University, China
Zheng Wang
Shanghai Jiao Tong University School of Medicine, ChinaSubmit your abstract Today
Title : A novel mRNA genomic technology for precision medicine, early cancer diagnosis, prognosis, treatment follow-up and cancer gene therapy
Rajvir Dahiya, University of California San Francisco, United States
Title : The future of pharmacogenetic polymorphism, pharmacogenomics and pharmamicrobiome in cancer treatment
Bene Ekine-Afolabi, University of East London, United Kingdom
Title : Biosensor-based detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Hospital care for cancer patients - safety, quality of care, education and respect for patient’s rights
Mariola Wioletta Borowska, Maria Sklodowska-Curie National Research Institute of Oncology, Poland
Title : Importin7 induces M2 macrophage and promotes the progress of colorectal cancer by regulating the nucleus translocation of GRP78
Changjiang Yang, Peking University People's Hospital, China
Title : Cancer-associated fibroblasts derived soluble CADM1 predicts response to neoadjuvant chemoimmunotherapy in lung cancer
Jian Li, Shanghai Jiaotong University, China